Unique HIV Risk Factors and Prevention Needs for Transgender Women and Cisgender Men Who Have Sex with Men in Bangkok, Thailand.
HIV
Thailand
sexual and gender minorities
transgender persons
Journal
Transgender health
ISSN: 2688-4887
Titre abrégé: Transgend Health
Pays: United States
ID NLM: 101691357
Informations de publication
Date de publication:
Aug 2023
Aug 2023
Historique:
pmc-release:
28
07
2024
medline:
2
8
2023
pubmed:
2
8
2023
entrez:
2
8
2023
Statut:
epublish
Résumé
Transgender women (TGW) and cisgender men who have sex with men (cis-MSM) are often grouped together as key populations. We evaluated behavioral and other characteristics that may distinguish TGW from cis-MSM in Bangkok, Thailand. We enrolled into an 18-month cohort cis-MSM and TGW 18-35 years of age without HIV, who reported anal intercourse plus condomless anal intercourse, multiple partners, transactional sex, and/or sexually transmitted infection. Robust multivariable Poisson regression was used to estimate adjusted prevalence ratios (aPRs) and confidence intervals (95% CIs) for associations with being a TGW. Among TGW, logistic regression with generalized estimating equations was used to estimate adjusted odds ratios (aORs) and 95% CIs for associations with taking hormones and having undergone gender affirmation surgery (GAS). From 2017 to 2019, 660 cis-MSM and 348 TGW were enrolled. Compared to cis-MSM, TGW were more likely to be attracted to mostly/only men (aPR: 3.79, 95% CI: 1.57-9.13), have a higher monthly income (aPR: 1.25, 95% CI: 1.04-1.50), have lived in their current residence for <1 year (aPR: 1.21, 95% CI: 1.01-1.46), have engaged in sex work (aPR: 1.48, 95% CI: 1.23-1.77), and be less likely to have ever undergone HIV testing (aPR: 0.83, 95% CI: 0.70-0.98). Among TGW, 149 (42.8%) were taking hormones and 33 (9.5%) had undergone GAS. GAS was more common among TGW who ever used methamphetamines (aOR: 1.55, 95% CI: 1.00-2.41) and those >23 years (18-20-year olds aOR: 0.17, 95% CI: 0.05-0.55; 21-23-year olds aOR: 0.36, 95% CI: 0.20-0.65). TGW and cis-MSM are unique populations; tailored, gender-affirming, differentiated models of HIV prevention and care are necessary to address vulnerabilities specific to each key population.
Sections du résumé
Background
UNASSIGNED
Transgender women (TGW) and cisgender men who have sex with men (cis-MSM) are often grouped together as key populations. We evaluated behavioral and other characteristics that may distinguish TGW from cis-MSM in Bangkok, Thailand.
Methods
UNASSIGNED
We enrolled into an 18-month cohort cis-MSM and TGW 18-35 years of age without HIV, who reported anal intercourse plus condomless anal intercourse, multiple partners, transactional sex, and/or sexually transmitted infection. Robust multivariable Poisson regression was used to estimate adjusted prevalence ratios (aPRs) and confidence intervals (95% CIs) for associations with being a TGW. Among TGW, logistic regression with generalized estimating equations was used to estimate adjusted odds ratios (aORs) and 95% CIs for associations with taking hormones and having undergone gender affirmation surgery (GAS).
Results
UNASSIGNED
From 2017 to 2019, 660 cis-MSM and 348 TGW were enrolled. Compared to cis-MSM, TGW were more likely to be attracted to mostly/only men (aPR: 3.79, 95% CI: 1.57-9.13), have a higher monthly income (aPR: 1.25, 95% CI: 1.04-1.50), have lived in their current residence for <1 year (aPR: 1.21, 95% CI: 1.01-1.46), have engaged in sex work (aPR: 1.48, 95% CI: 1.23-1.77), and be less likely to have ever undergone HIV testing (aPR: 0.83, 95% CI: 0.70-0.98). Among TGW, 149 (42.8%) were taking hormones and 33 (9.5%) had undergone GAS. GAS was more common among TGW who ever used methamphetamines (aOR: 1.55, 95% CI: 1.00-2.41) and those >23 years (18-20-year olds aOR: 0.17, 95% CI: 0.05-0.55; 21-23-year olds aOR: 0.36, 95% CI: 0.20-0.65).
Conclusions
UNASSIGNED
TGW and cis-MSM are unique populations; tailored, gender-affirming, differentiated models of HIV prevention and care are necessary to address vulnerabilities specific to each key population.
Identifiants
pubmed: 37529407
doi: 10.1089/trgh.2021.0192
pii: 10.1089/trgh.2021.0192
pmc: PMC10389251
doi:
Types de publication
Journal Article
Langues
eng
Pagination
371-380Informations de copyright
Copyright 2023, Mary Ann Liebert, Inc., publishers.
Déclaration de conflit d'intérêts
No competing financial interests exist.
Références
J Assoc Nurses AIDS Care. 2018 Sep - Oct;29(5):681-697
pubmed: 29716789
Lancet. 2015 Jan 17;385(9964):274-86
pubmed: 25059941
PLoS One. 2019 Jun 27;14(6):e0219169
pubmed: 31247030
BMC Public Health. 2017 Mar 11;17(1):245
pubmed: 28284184
J Int AIDS Soc. 2016 Jul 17;19(3 Suppl 2):20810
pubmed: 27431475
J Int AIDS Soc. 2019 Dec;22(12):e25430
pubmed: 31855324
Sex Transm Infect. 2018 Feb;94(1):51-54
pubmed: 29348258
AIDS Res Ther. 2019 Sep 6;16(1):25
pubmed: 31492161
N Engl J Med. 2009 Dec 3;361(23):2209-20
pubmed: 19843557
J Int AIDS Soc. 2021 Jun;24(6):e25683
pubmed: 34152695
J Virus Erad. 2016 Apr 01;2(2):87-93
pubmed: 27482441
Lancet Infect Dis. 2013 Mar;13(3):214-22
pubmed: 23260128
J Int AIDS Soc. 2020 Jan;23(1):e25448
pubmed: 31960589
EClinicalMedicine. 2021 Jul 17;38:101033
pubmed: 34505031
J Int AIDS Soc. 2020 Jun;23 Suppl 3:e25540
pubmed: 32602660
Lancet. 2016 Jul 23;388(10042):412-436
pubmed: 27323919
Infect Dis Poverty. 2019 Dec 1;8(1):94
pubmed: 31785621
AIDS Behav. 2008 Jan;12(1):1-17
pubmed: 17694429
Am J Public Health. 2015 Sep;105(9):1917-25
pubmed: 26180964
J Int AIDS Soc. 2017 Apr 20;20(1):21489
pubmed: 28453241
AIDS Care. 2022 Oct;34(10):1305-1313
pubmed: 34424784
Glob Public Health. 2016 Aug-Sep;11(7-8):835-48
pubmed: 26785751
PLoS One. 2018 Aug 30;13(8):e0203294
pubmed: 30161226
Sex Health. 2021 Mar;18(1):21-30
pubmed: 33632379
Am J Epidemiol. 2004 Apr 1;159(7):702-6
pubmed: 15033648
Cult Health Sex. 2022 Sep;24(9):1199-1214
pubmed: 34254893
J Int AIDS Soc. 2020 Oct;23 Suppl 6:e25596
pubmed: 33000908
Sex Transm Infect. 2019 Nov;95(7):534-539
pubmed: 30982000
Int J Epidemiol. 2010 Aug;39(4):1048-63
pubmed: 20406794
Int J STD AIDS. 2019 Apr;30(5):430-439
pubmed: 30626283
Sex Health. 2018 Nov;15(6):542-555
pubmed: 30249317
SSM Popul Health. 2020 May 28;11:100608
pubmed: 32529022
Am J Public Health. 2017 Feb;107(2):207-212
pubmed: 27997228
BMJ Open. 2017 Aug 11;7(8):e015390
pubmed: 28801398